Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment
Ovarian cancers are a complex and heterogenic group of malignancies that are difficult to detect, diagnose and treat. Fortunately, considerable knowledge of ovarian cancer specific biomarkers has been generated, that is pertinent to the development of novel theranostic platforms by combining therapi...
Saved in:
Main Authors: | Weranga Rajapaksha (Author), Riya Khetan (Author), Ian R. D. Johnson (Author), Anton Blencowe (Author), Sanjay Garg (Author), Hugo Albrecht (Author), Todd A. Gillam (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation
by: Riya Khetan, et al.
Published: (2024) -
Composition-Property Relationships of pH-Responsive Poly[(2-vinylpyridine)-co-(butyl methacrylate)] Copolymers for Reverse Enteric Coatings
by: Kyle Brewer, et al.
Published: (2023) -
Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction
by: Mohammad Arafat, et al.
Published: (2020) -
Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer
by: Ravit Edelman, et al.
Published: (2019) -
Financial incentive schemes in primary care
by: Gillam S
Published: (2015)